FIGS (FIGS) Rally Puts Fair Value Questions Back On The Table

Why FIGS Stock Is Back Under the Microscope

Recent debate over FIGS (FIGS) and its elevated P/E ratio has been triggered by the stock’s long term share price gains, pushing investors to reassess how much optimism is currently priced in.

FIGS is trading at US$19.12 after a powerful run, with a 30 day share price return of 46.4% and a 90 day share price gain of 86.35% that contributes to a 1 year total shareholder return of 143.26%, suggesting momentum has been building rather than fading.

Compare FIGS’s sharp rerating with other consumer-focused stocks that are seeing strong price momentum and solid fundamentals in our curated list of 20 high quality undiscovered gems.

FIGS now trades slightly above the average analyst price target, and the intrinsic value estimate points even lower. So where does a reasonable view of fair value actually fall after this kind of run up?

Most Popular Narrative: 33% Overvalued

According to the most followed FIGS narrative, the shares at $19.12 trade well above an assessed fair value of $14.39, so the recent rally is being weighed against a higher required return of 9% used in that framework.

FIGS concentrates on a specific niche within the healthcare industry, medical professionals. The company sells primary apparel, as well as related products. By catering to the unique needs and preferences of this market segment, FIGS tailors its products to precisely match their requirements. This has allowed the company to develop a brand synonymous with this segment, improving its competitive positioning.

See why 24 investors see FIGS as 33% overvalued.

According to julio, that focused positioning, direct to consumer model and data heavy approach support a detailed narrative that still lands on a fair value that is 32.9% below the market price. This frames FIGS as expensive on this narrative rather than as a cheap momentum story.

Result: Fair Value of $14.39 (OVERVALUED)

Still, the FIGS narrative can be knocked off course if margin targets prove hard to hit or if FX swings start to erode overseas earnings.

Find out about the key risks to this FIGS narrative.

Next Steps

Plenty of investors see FIGS as stretched on valuation, while others point to clear upside drivers on the horizon. Now is the moment to dig into the underlying data and pressure test the bullish and cautious arguments side by side by weighing the 2 key rewards and 1 important warning sign.

Looking For More Investment Ideas Beyond FIGS?

If FIGS has you rethinking what is already priced in, do not stop here. Broader idea hunting can sharpen your judgment and surface better risk reward trade offs.

• Target resilient compounding potential by scanning companies with robust finances and healthy balance sheets through the list of solid balance sheet and fundamentals (25 results).
• Hunt for quality at a reasonable price by reviewing the 33 high quality undervalued stocks that align strong fundamentals with more modest market expectations.
• Prioritise stability and income potential by checking the 8 dividend fortresses that pair higher yields with a focus on durability.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com